is retatrutide fda approved october 2025 Warning: What GLP-1 Providers Must Know Now This weight-loss drug hasn't been

N Engl J Med (2015) 372(14):133341

Mounjaro ~22.5% average body weight loss Significant weight reduction Improves blood sugar levels Clinically proven weight loss Wegovy ~16.9% average body weight loss Boosts metabolic & cardiovascular health Proven, long-established safety profile Weekly injection, easy to use

Each one has a completely different dosing frequency

Eli Lilly must complete all seven TRIUMPH Phase 3 trials and submit a New Drug Application before the FDA's 10-month review process begins

Approved medications have completed large Phase 3 trials and come with a clear, regulated dosing label

Weight-loss medications and treatments should only be used under the guidance of a licensed healthcare professional